Open AccessInitial Effects of COVID-19 on Patients with ESKD
Author(s) -
Eric D. Weinhandl,
James B. Wetmore,
Yi Peng,
Jiang Liu,
David T. Gilbertson,
Kirsten L. Johansen
Publication year - 2021
Publication title -
journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.451
H-Index - 279
eISSN - 1533-3450
pISSN - 1046-6673
DOI - 10.1681/asn.2021010009
Subject(s) - medicine , case fatality rate , dialysis , covid-19 , confidence interval , renal replacement therapy , kidney disease , mortality rate , peritoneal dialysis , population , pandemic , epidemiology , disease , infectious disease (medical specialty) , environmental health
Reports from around the world have indicated a fatality rate of patients with coronavirus disease 2019 (COVID-19) in the range of 20%-30% among patients with ESKD. Population-level effects of COVID-19 on patients with ESKD in the United States are uncertain.